Phase III study of sunitinib malate (SU11248) versus interferon-α as first-line treatment in patients with metastatic renal cell carcinoma

被引：19

作者：

Reddy, Kesava

机构：

来源：

CLINICAL GENITOURINARY CANCER | 2006年 / 5卷 / 01期

关键词：

D O I：

10.1016/S1558-7673(11)70151-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：23 / 25

页数：3

共 8 条

[1]

[Anonymous], **NON-TRADITIONAL**

[2] Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma [J].

Motzer, RJ ;

Michaelson, MD ;

Redman, BG ;

Hudes, GR ;

Wilding, G ;

Figlin, RA ;

Ginsberg, MS ;

Kim, ST ;

Baum, CM ;

DePrimo, SE ;

Li, JZ ;

Bello, CL ;

Theuer, CP ;

George, DJ ;

Rini, BI .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (01) :16-24

[3]

MOTZER RJ, 2006, 42 ANN M AM SOC CLIN

[4] Sunitinib in patients with metastatic renal cell carcinoma [J].

Motzer, Robert J. ;

Rini, Brian I. ;

Bukowski, Ronald M. ;

Curti, Brendan D. ;

George, Daniel J. ;

Hudes, Gary R. ;

Redman, Bruce G. ;

Margolin, Kim A. ;

Merchan, Jaime R. ;

Wilding, George ;

Ginsberg, Michelle S. ;

Bacik, Jennifer ;

Kim, Sindy T. ;

Baum, Charles M. ;

Michaelson, M. Dror .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (21) :2516-2524

[5] SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo [J].

O'Farrell, AM ;

Abrams, TJ ;

Yuen, HA ;

Ngai, TJ ;

Louie, SG ;

Yee, KWH ;

Wong, LM ;

Hong, W ;

Lee, LB ;

Town, A ;

Smolich, BD ;

Manning, WC ;

Murray, LJ ;

Heinrich, MC ;

Cherrington, JM .

BLOOD, 2003, 101 (09) :3597-3605

[6] Contribution of individual targets to the antitumor efficacy of the multitargeted receptor tyrosine kinase inhibitor SU11248 [J].

Potapova, Olga ;

Laird, A. Douglas ;

Nannini, Michelle A. ;

Barone, Angela ;

Li, Guangmin ;

Moss, Katherine G. ;

Cherrington, Julie M. ;

Mendel, Dirk B. .

MOLECULAR CANCER THERAPEUTICS, 2006, 5 (05) :1280-1289

[7]

RAYMOND E, 2003, P AN M AM SOC CLIN, V22, P192

[8]

Schueneman AJ, 2003, CANCER RES, V63, P4009

← 1 →